ArticleThe Journal of pharmacology and experimental therapeutics2022

Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB.

N Matthew Ellinwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.